Kestra Medical Technologies (KMTS) Amortization of Deferred Charges (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Amortization of Deferred Charges data on file, last reported at $468000.0 in Q2 2026.

• On a quarterly basis, Amortization of Deferred Charges rose 26.83% year-over-year to $468000.0 in Q2 2026; TTM through Apr 2026 was $1.9 million, a 33.86% increase from a year earlier, with the FY2026 full-year figure at $1.9 million, up 33.86% from the prior year.
• Amortization of Deferred Charges for Q2 2026 stood at $468000.0, roughly flat from $469000.0 in the prior quarter.
• Over the last five years, Amortization of Deferred Charges for KMTS reached as high as $661000.0 in Q4 2024 and fell as low as $170000.0 in Q1 2025.
• Historically, Amortization of Deferred Charges has averaged $386000.0 across 3 years, with a median of $468000.0 in 2025.
• Across the five-year window, Amortization of Deferred Charges fell 29.2% in 2025 and jumped 175.88% in 2026, its largest moves.
• Year by year, Amortization of Deferred Charges stood at $661000.0 in 2024, then fell by 29.2% to $468000.0 in 2025, then changed by 0.0% to $468000.0 in 2026.
• Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $468000.0 in Q2 2026, $469000.0 in Q1 2026, and $468000.0 in Q4 2025.